Walleye Capital’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,500
Closed -$537K 5263
2024
Q4
$537K Hold
20,500
﹤0.01% 2923
2024
Q3
$495K Sell
20,500
-8,000
-28% -$151K ﹤0.01% 3310
2024
Q2
$494K Buy
28,500
+25,700
+918% +$452K ﹤0.01% 3527
2024
Q1
$44.9K Sell
2,800
-700
-20% -$14.7K ﹤0.01% 4712
2023
Q4
$95.7K Buy
+3,500
New +$92.4K ﹤0.01% 4057

Other funds holding ZLAB

Walleye Capital's ZLAB Position: Q1 2026 in Review

Walleye Capital reduced its Zai Lab (ZLAB) stake by 75% in Q1 2026, selling an estimated $5.17M and leaving 94,678 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #1562.

Walleye Capital first reported a position in ZLAB in Q1 2024 and has held it in 8 quarters since. The position peaked at $6.59M in Q4 2025. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • Walleye Capital held 94,678 shares of Zai Lab worth $1.78M as of Q1 2026.
  • Walleye Capital sold 278,721 Zai Lab shares in Q1 2026, an estimated $5.17M.
  • Zai Lab made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1562 holding.
  • Walleye Capital first reported a position in Zai Lab in Q1 2024 and has held it in 8 quarters since.
  • Walleye Capital's Zai Lab position peaked at $6.59M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.